Simplex Trading
TXG icon

Simplex Trading’s 10x Genomics TXG Stock Holding History

Simplex Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$752K Buy
35,400
+25,300
+250% +$506K ﹤0.01% 2797
2025
Q4 		$165K Sell
10,100
-164,200
-94% -$2.48M ﹤0.01% 4431
2025
Q3 		$2.04M Buy
174,300
+160,500
+1,163% +$2.09M ﹤0.01% 2310
2025
Q2 		$159K Sell
13,800
-8,000
-37% -$72.9K ﹤0.01% 4752
2025
Q1 		$190K Buy
21,800
+17,800
+445% +$224K ﹤0.01% 4394
2024
Q4 		$57K Sell
4,000
-7,800
-66% -$123K ﹤0.01% 5749
2024
Q3 		$266K Sell
11,800
-6,700
-36% -$139K ﹤0.01% 4250
2024
Q2 		$359K Sell
18,500
-4,400
-19% -$115K ﹤0.01% 4022
2024
Q1 		$859K Sell
22,900
-33,700
-60% -$1.48M ﹤0.01% 3285
2023
Q4 		$3.17M Sell
56,600
-148,500
-72% -$6.46M ﹤0.01% 1948
2023
Q3 		$8.46M Buy
205,100
+176,500
+617% +$9.18M 0.01% 1007
2023
Q2 		$1.6M Sell
28,600
-18,600
-39% -$1.01M ﹤0.01% 2162
2023
Q1 		$2.63M Buy
47,200
+43,700
+1,249% +$2.04M ﹤0.01% 1714
2022
Q4 		$127K Sell
3,500
-38,600
-92% -$1.26M ﹤0.01% 4788
2022
Q3 		$1.2M Buy
42,100
+34,600
+461% +$1.32M ﹤0.01% 2445
2022
Q2 		$339K Sell
7,500
-10,600
-59% -$550K ﹤0.01% 3941
2022
Q1 		$1.38M Buy
18,100
+12,400
+218% +$1.08M ﹤0.01% 2511
2021
Q4 		$849K Sell
5,700
-12,000
-68% -$1.84M ﹤0.01% 3085
2021
Q3 		$3.36M Hold
17,700
– – ﹤0.01% 1562
2021
Q2 		$3.47M Buy
17,700
+17,681
+93,058% +$3.2M ﹤0.01% 1527
2021
Q1 		$343K Sell
19
-350
-95% -$60.4K ﹤0.01% 3960
2020
Q4 		$5.22M Buy
369
+91
+33% +$13.2K 0.01% 959
2020
Q3 		$3.47M Sell
278
-12
-4% -$1.26K ﹤0.01% 1103
2020
Q2 		$2.59M Buy
290
+254
+706% +$19.8K ﹤0.01% 1307
2020
Q1 		$224K Buy
36
+19
+112% +$1.48K ﹤0.01% 3465
2019
Q4 		$129K Buy
+17
New +$1.02K ﹤0.01% 4238

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TXG Position: Q1 2026 in Review

Simplex Trading sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 15,986 shares — an estimated $320K sold.

Simplex Trading first reported a position in TXG in Q4 2019 and held it in 12 quarters. The position peaked at $794K in Q4 2023. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Simplex Trading reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 15,986 10x Genomics shares in Q1 2026, an estimated $320K.
  • Simplex Trading first reported a position in 10x Genomics in Q4 2019 and held it in 12 quarters.
  • Simplex Trading's 10x Genomics position peaked at $794K in Q4 2023.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.